Aroa Biosurgery (ASX: ARX) Share Price

ARX

$0.65▲+5.69%

$224.6MRank #630 on ASXHealthcareMedical - Devices

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$224.6M

Volume

180K

P/E Ratio

9.96

EPS

$0.0149

Dividend Yield

0.00%

52-Week High

$0.80

52-Week Low

$0.46

Beta

0.843

Aroa Biosurgery (ASX: ARX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $224.6M and the 630th-largest security on the ASX by market capitalisation. The ARX share price is $0.65, up 5.69% today and up 30.00% over the past 12 months. Shares have traded between $0.46 and $0.80 over the past 52 weeks. ARX trades on a price-to-earnings ratio of 9.96, below the Healthcare sector median of 14.96. In its most recent reported period (ending 31 Mar 2026), Aroa Biosurgery reported revenue of $50.8M and a net profit of $5.2M (10.1% margin).

Charts

$0.65

24H Range

$0.61

$0.66

52-Week Range

$0.46

$0.80

About Aroa Biosurgery Limited

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

IPO Date

24 July 2020

CEO

Brian Ward

Employees

273

Website

aroabio.com

Key Financial Data

Revenue (Quarterly)	$50.8M
Net Income (Quarterly)	$5.2M
Total Assets	$100.5M
Total Debt	$5.3M
Free Cash Flow	$4.9M
Return on Equity	6.23%
Profit Margin	10.13%
Operating Margin	11.44%

ARX Frequently Asked Questions

What is the Aroa Biosurgery (ASX: ARX) share price?

The ARX share price is $0.65, up 5.69% for the day, based on the latest available ASX market data.

What is Aroa Biosurgery's market capitalisation?

Aroa Biosurgery has a market capitalisation of $224.6M, making it the 630th-largest security listed on the ASX.

Does Aroa Biosurgery pay a dividend?

ARX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

What is ARX's P/E ratio?

Aroa Biosurgery trades on a trailing price-to-earnings (P/E) ratio of 9.96, based on its current share price and most recent reported earnings.

Is Aroa Biosurgery profitable?

Yes. In its most recent reported period (ending 31 Mar 2026), ARX reported revenue of $50.8M and a net profit of $5.2M.

How many ARX shares are on issue?

Aroa Biosurgery has approximately 345,472,395 shares on issue, based on its market capitalisation of $224.6M and current share price.

What sector is Aroa Biosurgery in?

Aroa Biosurgery is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.

When did Aroa Biosurgery list on the ASX?

Aroa Biosurgery listed on the Australian Securities Exchange on 24 July 2020.

Latest News

Aroa Biosurgery Limited (ASX:ARX)

intelligentinvestor.com.au29 May 2026

Aroa Biosurgery Limited (ASX:ARX) intelligentinvestor.com.au

Why Aroa Biosurgery’s (ASX:ARX) EBITDA Turnaround Is Catching Investor Attention

Kalkine26 May 2026

Why Aroa Biosurgery’s (ASX:ARX) EBITDA Turnaround Is Catching Investor Attention Kalkine

Aroa Biosurgery (ASX:ARX) TTM Profitability Emerges

simplywall.st27 May 2026

Aroa Biosurgery (ASX:ARX) TTM Profitability Emerges simplywall.st

Health Check: Investors say “not baa-d” as Aroa smashes earnings expectations out of the paddock

Stockhead30 Apr 2026

Health Check: Investors say “not baa-d” as Aroa smashes earnings expectations out of the paddock Stockhead

While institutions own 32% of Aroa Biosurgery Limited (ASX:ARX), individual investors are its largest shareholders with 42% ownership

Yahoo Finance15 Nov 2025

While institutions own 32% of Aroa Biosurgery Limited (ASX:ARX), individual investors are its largest shareholders with 42% ownership Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
AVRAnteris Technologies Ltd	$482.7M	$13.12	-0.94	0.00%	▼-2.81%
IMRImricor Medical Systems, Inc.	$436.7M	$1.75	-6.61	0.00%	▲+4.17%
AFPAFT Pharmaceuticals Limited	$321.9M	$3.07	7.71	0.00%	▼-5.54%
TTXTetratherix Ltd.	$317.6M	$6.00	—	—	▲+14.29%
MVFMonash IVF Group Limited	$266.9M	$0.685	10.00	0.00%	▲+2.24%
OCCOrthocell Limited	$163.2M	$0.735	-12.98	0.00%	▼-1.34%
AVHAVITA Medical, Inc.	$134.2M	$1.08	-26.62	0.00%	▼-5.68%
SOMSomnoMed Limited	$115.0M	$0.525	52.88	0.00%	▼-9.48%

ETFs That Hold ARX

ARX is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund	Portfolio Weight	Fund Size
VISMVanguard MSCI International Small Companies Index ETF	0.01%	$906.8M
VTSVanguard U.S. Total Market Shares Index ETF	0.00%	$9.53B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.61	$0.66	$0.61	$0.65	180K	▲+5.69%
11 June 2026	$0.65	$0.65	$0.615	$0.615	200K	▼-3.15%
10 June 2026	$0.65	$0.655	$0.635	$0.635	275K	▼-1.55%
9 June 2026	$0.665	$0.665	$0.635	$0.645	192K	–+0.00%
8 June 2026	$0.662	$0.662	$0.62	$0.645	75K	–+0.00%
5 June 2026	$0.662	$0.662	$0.62	$0.645	75K	▼-0.77%
4 June 2026	$0.675	$0.675	$0.645	$0.65	132K	▼-2.26%
3 June 2026	$0.675	$0.675	$0.645	$0.665	66K	–+0.00%
2 June 2026	$0.655	$0.675	$0.65	$0.665	175K	▲+0.76%
1 June 2026	$0.68	$0.685	$0.66	$0.66	101K	▼-3.23%
29 May 2026	$0.67	$0.70	$0.665	$0.682	358K	▲+2.56%
28 May 2026	$0.68	$0.69	$0.665	$0.665	400K	▼-0.75%
27 May 2026	$0.63	$0.695	$0.62	$0.67	429K	▲+8.59%
26 May 2026	$0.63	$0.64	$0.61	$0.617	665K	▲+0.33%
25 May 2026	$0.615	$0.62	$0.60	$0.615	132K	▲+2.50%
22 May 2026	$0.60	$0.615	$0.595	$0.60	105K	▲+1.35%
21 May 2026	$0.60	$0.605	$0.59	$0.592	99K	▼-1.33%
20 May 2026	$0.595	$0.615	$0.59	$0.60	113K	▲+1.69%
19 May 2026	$0.60	$0.605	$0.59	$0.59	87K	▼-1.67%
18 May 2026	$0.615	$0.615	$0.60	$0.60	152K	▼-3.23%
15 May 2026	$0.62	$0.62	$0.61	$0.62	221K	–+0.00%
14 May 2026	$0.63	$0.63	$0.605	$0.62	73K	▲+0.81%
13 May 2026	$0.62	$0.62	$0.61	$0.615	208K	▼-0.81%
12 May 2026	$0.62	$0.62	$0.61	$0.62	135K	–+0.00%
11 May 2026	$0.65	$0.65	$0.60	$0.62	448K	▼-2.36%
8 May 2026	$0.67	$0.675	$0.63	$0.635	183K	▼-1.55%
7 May 2026	$0.675	$0.675	$0.635	$0.645	133K	▼-0.77%
6 May 2026	$0.62	$0.655	$0.62	$0.65	301K	▲+5.69%
5 May 2026	$0.64	$0.64	$0.61	$0.615	168K	▼-3.91%
4 May 2026	$0.64	$0.675	$0.625	$0.64	152K	▲+1.59%

About Aroa Biosurgery Limited

IPO Date

24 July 2020

CEO

Brian Ward

Employees

273

Website

aroabio.com

ARX Frequently Asked Questions

What is the Aroa Biosurgery (ASX: ARX) share price?

The ARX share price is $0.65, up 5.69% for the day, based on the latest available ASX market data.

What is Aroa Biosurgery's market capitalisation?

Aroa Biosurgery has a market capitalisation of $224.6M, making it the 630th-largest security listed on the ASX.

Does Aroa Biosurgery pay a dividend?

ARX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

What is ARX's P/E ratio?

Aroa Biosurgery trades on a trailing price-to-earnings (P/E) ratio of 9.96, based on its current share price and most recent reported earnings.

Is Aroa Biosurgery profitable?

Yes. In its most recent reported period (ending 31 Mar 2026), ARX reported revenue of $50.8M and a net profit of $5.2M.

How many ARX shares are on issue?

Aroa Biosurgery has approximately 345,472,395 shares on issue, based on its market capitalisation of $224.6M and current share price.

What sector is Aroa Biosurgery in?

Aroa Biosurgery is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.

When did Aroa Biosurgery list on the ASX?

Aroa Biosurgery listed on the Australian Securities Exchange on 24 July 2020.

Company

Market Cap

Price

P/E

Div Yield

1D Change

AVRAnteris Technologies Ltd

$482.7M

$13.12

-0.94

0.00%

▼-2.81%

IMRImricor Medical Systems, Inc.

$436.7M

$1.75

-6.61

0.00%

▲+4.17%

AFPAFT Pharmaceuticals Limited

$321.9M

$3.07

7.71

0.00%

▼-5.54%

TTXTetratherix Ltd.

$317.6M

$6.00

—

▲+14.29%

MVFMonash IVF Group Limited

$266.9M

$0.685

10.00

0.00%

▲+2.24%

OCCOrthocell Limited

$163.2M

$0.735

-12.98

0.00%

▼-1.34%

AVHAVITA Medical, Inc.

$134.2M

$1.08

-26.62

0.00%

▼-5.68%

SOMSomnoMed Limited

$115.0M

$0.525

52.88

0.00%

▼-9.48%

ETFs That Hold ARX

ARX is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund

Portfolio Weight

Fund Size

VISMVanguard MSCI International Small Companies Index ETF

0.01%

$906.8M

VTSVanguard U.S. Total Market Shares Index ETF

0.00%

$9.53B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.61	$0.66	$0.61	$0.65	180K	▲+5.69%
11 June 2026	$0.65	$0.65	$0.615	$0.615	200K	▼-3.15%
10 June 2026	$0.65	$0.655	$0.635	$0.635	275K	▼-1.55%
9 June 2026	$0.665	$0.665	$0.635	$0.645	192K	–+0.00%
8 June 2026	$0.662	$0.662	$0.62	$0.645	75K	–+0.00%
5 June 2026	$0.662	$0.662	$0.62	$0.645	75K	▼-0.77%
4 June 2026	$0.675	$0.675	$0.645	$0.65	132K	▼-2.26%
3 June 2026	$0.675	$0.675	$0.645	$0.665	66K	–+0.00%
2 June 2026	$0.655	$0.675	$0.65	$0.665	175K	▲+0.76%
1 June 2026	$0.68	$0.685	$0.66	$0.66	101K	▼-3.23%
29 May 2026	$0.67	$0.70	$0.665	$0.682	358K	▲+2.56%
28 May 2026	$0.68	$0.69	$0.665	$0.665	400K	▼-0.75%
27 May 2026	$0.63	$0.695	$0.62	$0.67	429K	▲+8.59%
26 May 2026	$0.63	$0.64	$0.61	$0.617	665K	▲+0.33%
25 May 2026	$0.615	$0.62	$0.60	$0.615	132K	▲+2.50%
22 May 2026	$0.60	$0.615	$0.595	$0.60	105K	▲+1.35%
21 May 2026	$0.60	$0.605	$0.59	$0.592	99K	▼-1.33%
20 May 2026	$0.595	$0.615	$0.59	$0.60	113K	▲+1.69%
19 May 2026	$0.60	$0.605	$0.59	$0.59	87K	▼-1.67%
18 May 2026	$0.615	$0.615	$0.60	$0.60	152K	▼-3.23%
15 May 2026	$0.62	$0.62	$0.61	$0.62	221K	–+0.00%
14 May 2026	$0.63	$0.63	$0.605	$0.62	73K	▲+0.81%
13 May 2026	$0.62	$0.62	$0.61	$0.615	208K	▼-0.81%
12 May 2026	$0.62	$0.62	$0.61	$0.62	135K	–+0.00%
11 May 2026	$0.65	$0.65	$0.60	$0.62	448K	▼-2.36%
8 May 2026	$0.67	$0.675	$0.63	$0.635	183K	▼-1.55%
7 May 2026	$0.675	$0.675	$0.635	$0.645	133K	▼-0.77%
6 May 2026	$0.62	$0.655	$0.62	$0.65	301K	▲+5.69%
5 May 2026	$0.64	$0.64	$0.61	$0.615	168K	▼-3.91%
4 May 2026	$0.64	$0.675	$0.625	$0.64	152K	▲+1.59%